Peer Review reports
From: Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
| Original Submission | ||
|---|---|---|
| 23 Sep 2020 | Submitted | Original manuscript |
| 7 Oct 2020 | Author responded | Author comments - Tingting Li |
| Resubmission - Version 2 | ||
| 7 Oct 2020 | Submitted | Manuscript version 2 |
| 26 Oct 2020 | Reviewed | Reviewer Report |
| 11 Nov 2020 | Reviewed | Reviewer Report |
| 20 Nov 2020 | Reviewed | Reviewer Report |
| 1 Dec 2020 | Author responded | Author comments - Tingting Li |
| Resubmission - Version 3 | ||
| 1 Dec 2020 | Submitted | Manuscript version 3 |
| 3 Dec 2020 | Reviewed | Reviewer Report |
| 6 Dec 2020 | Reviewed | Reviewer Report |
| 9 Dec 2020 | Reviewed | Reviewer Report |
| 14 Dec 2020 | Author responded | Author comments - Tingting Li |
| Resubmission - Version 4 | ||
| 14 Dec 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 15 Dec 2020 | Editorially accepted | |
| 7 Jan 2021 | Article published | 10.1186/s12872-020-01827-0 |
You can find further information about peer review here.